Published June 15, 2026
The addition of GIP agonism in tirzepatide enhances first- and second-phase insulin secretion, reduces fasting and postprandial glucagon concentrations and therefore reduces postprandial glucose levels further
Serious allergic reactions (hypersensitivity reaction)
[DOI] [PMC free article] [PubMed] [Google Scholar] 46.Braidy N., Guillemin G.J., Mansour H., Chan-Ling T., Poljak A., Grant R
This pattern is consistent with broader GLP-1 research showing women achieving approximately 11 percent greater relative weight loss than men across studies
Ajay Goyal, FACS Weight Loss Medications, GLP-1 Injections and GLP-1 Pill Comparison Medications Zepbound (GLP-1 Tirzepatide) (GLP-1 Tirzepatide) Wegovy (GLP-1 Semaglutide) (GLP-1 Semaglutide) Saxenda (Liraglutide) (Liraglutide) Wegovy Pill (GLP-1 Semaglutide) (GLP-1 Semaglutide) Foundayo (orforglipron) (orforglipron) Qsymia (Phentermine & Topiramate) (Phentermine & Topiramate) What to Expect One weekly injection One weekly injection One injection daily One tablet daily One tablet daily One tablet daily How it helps you lose weight Reduce appetite, food intake, body fat and body weight Increase satiety and control portions Increase satiety and control portions Increase satiety and control portions Slows digestion and reduces appetite Suppress appetite and control cravings Weight loss 16-20% of body weight 4 15-18% of body weight 5 15-18% of body weight 6 14-17% of body weight 11-12.4% of body weight 10% of body weight 7 *Our board-certified doctors prescribe FDA-approved prescription GLP-1 medications and injections to people in NJ who meet the clinical qualifications
